Trial Profile
A study of On-Demand use of Anakinra for the attacks of Familial Mediterranean Fever
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2018
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Familial Mediterranean fever
- Focus Therapeutic Use
- 15 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism